Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
I-Mab Biopharma
Biotech
I-Mab sheds China footprint to transform into US-based biotech
I-Mab’s plan to become a U.S.-focused biotech took a stride forward with the news that the company is divesting its China operations.
James Waldron
Feb 7, 2024 8:50am
I-Mab hits the deal table with biopharma majors: report
Sep 29, 2021 8:20am
I-Mab thinks cytokine storm drug can take on Humanigen
Aug 11, 2021 12:11pm
I-Mab boards mRNA, AI trains with 2 biotech collaboration deals
Jul 9, 2021 10:12am
I-Mab's uliledlimab sees positive data in Tecentriq combo test
May 19, 2021 6:00pm
I-Mab's IL-6 drug hits goal in ulcerative colitis phase 2
Apr 26, 2021 8:45am
